28.08.2012
- AstraZeneca has poached Pascal Soriot from rival Roche Holding to be its new chief executive, hoping his track record in drug innovation and dealmaking can revive a company...
03.08.2012
- Global biotech merger volume has reached levels not seen in four years as big pharmaceutical companies pursue deals to get access to new drugs, with bankers saying therapeutic...
27.07.2012
- A U.S. Food and Drug Administration panel on Thursday recommended two drugs for combating different forms of vision loss that can lead to blindness among a range of adults...
26.07.2012
- Europe's sick economy is infecting its pharmaceuticals sector, traditionally one of the region's most successful industries. Price cuts to rein in healthcare spending reached...
26.07.2012
- Swiss drugmaker Roche Holding took $1.7 billion in restructuring charges it said should lead to big savings as it confirmed its outlook on Thursday with first-half sales beating...
24.07.2012
- Biogen said on Tuesday its second-quarter earnings topped expectations on higher sales of its drugs to treat multiple sclerosis, and the company increased its profit forecast for...
18.07.2012
- Large investors in U.S. biotech companies are likely to capture serious windfall profits as deal activity picks up in the sector. A Reuters analysis of investors' average cost...
03.07.2012
- When Roche paid $46.8 billion in 2009 to gain full ownership of Genentech, fears were rife that the arrival of the Swiss men in suits would stifle the free-wheeling innovative...
